Ultrahuman brings biological-age model to UAE through Abu Dhabi deal

Health technology startup Ultrahuman has announced a major strategic partnership with health authorities in Abu Dhabi to roll out a novel biological-age model across the United Arab Emirates. Best known globally for its smart rings, the Bengaluru-based company signed a two-year memorandum of understanding with the Abu Dhabi Public Health Center to research, develop, and clinically validate the advanced longevity system. This initiative represents a significant evolution for Ultrahuman, moving the company beyond a pure hardware manufacturer into a broader health-data analytics provider. According to CEO Mohit Kumar, while the smart ring remains a crucial tool for capturing physiological signals, the true value of the business lies in the sophisticated algorithms built on top of that collected data. By collaborating directly with government entities, Ultrahuman gains access to a population-scale deployment model that far exceeds the reach of its traditional commercial customer base.

The core of the new partnership centers on a biological-age model designed to estimate the rate atid which an individual is aging based on continuous lifestyle and physiological signals. The system analyzes critical health markers including sleep quality, physical activity levels, cardiovascular health, and metabolic indicators to identify lifestyle factors that either accelerate or decelerate the aging process. Crucially, the model is being engineered to be entirely wearable-agnostic. This means that data from various consumer devices, such as smart rings, wrist-worn trackers, fitness straps, and health patches, can seamlessly feed into the platform alongside official clinical biomarkers. By decoupling the analytical software from any single hardware brand, the system can achieve much wider adoption among diverse demographic groups throughout the region.

For the residents of the UAE, accessing these insights will eventually become as simple as logging into established government digital-health platforms, including TAMM and Sahatna. The ongoing research and clinical validation phase will span two years, during which Ultrahuman and local health authorities will rigorously test and refine the model. While a definitive timeline for the full public rollout has not yet been finalized, the deployment will occur in carefully managed phases. The UAE already represents a robust and highly engaged market for Ultrahuman, accounting for roughly 4% to 5% of the company's total global revenue. Having operated in the country for nearly five years, Ultrahuman reports user retention rates that are approximately 25% higher there compared to many of its other international markets.

Expanding this technology to a national scale also solves a fundamental demographic limitation for the health tech startup. While Ultrahuman's current commercial user base largely consists of digitally savvy individuals between the ages of 25 and 43, integrating the model into the broader UAE public health infrastructure will expose the algorithms to a much wider spectrum of ages and lifestyles. The underlying biological-age model was initially constructed using historical datasets that combined chronological age with wearable metrics and select blood-test markers, helping researchers establish baseline aging patterns and spot deviations. Company leadership has emphasized that the deployed algorithm will process local data securely, ensuring that Ultrahuman will not have access to any personally identifiable information. This venture is part of a broader trend in Abu Dhabi, which also partnered with other wearable technology makers earlier in the year to champion preventive healthcare initiatives.